Table 1.
Theme of care | Guideline statement | Criteria | Standards |
---|---|---|---|
Assessment of gout patients |
All patients presenting with acute gout should have SUA, renal function and glucose assessed 4-6wk after acute attack [3] |
1.1 Adult patients with a diagnosis of gout have ever had a recorded SUA |
≥90% |
1.2 Adult patients with a diagnosis of gout have ever had a recorded eGFR |
≥90% |
||
1.3 Adult patients with a diagnosis of gout have had a recorded serum glucose since diagnosis |
≥90% |
||
Management of recurrent gout |
The therapeutic goal of urate lowering therapy…is achieved by maintaining the SUA below the saturation point for urate (≤360 μmol/l) [4] |
2.1 Adult patients currently prescribed (prescription in the last 2 months) allopurinol have a SUA measured in the last year |
≥90% |
2.2 Adult patients currently prescribed (prescription in the last 2 months) allopurinol have an SUA ≤ 360 μmol/l |
≥80% |
||
Monitoring of gout patients |
Annual measurements of plasma renal function and SUA [3] |
3.1 Adult patients with a diagnosis of gout have had a SUA in the last year |
≥90% |
3.2 Adult patients with a diagnosis of gout have had a eGFR measured in the last year |
≥90% |
||
Lifestyle advice |
All patients with gout should be given advice about diet, alcohol restriction, weight management and fluid intake.[3,4] |
4.1 Adult patients with a diagnosis of gout with evidence of advice regarding diet recorded |
≥90% |
[It is recognised that such information may be provided in written format in a patient information leaflet] |
4.2 Adult patients with a diagnosis of gout with evidence of advice regarding alcohol recorded |
≥90% |
|
4.3 Adult patients with a diagnosis of gout with evidence of advice regarding fluid intake recorded |
≥90% |
||
4.4 Adult patients with a diagnosis of gout have a record of BMI |
≥90% |
||
Addressing comorbidities | Associated comorbidities and cardiovascular risk factors should be addressed as an important part of the management of gout [4] |
5.1 Adult patients with a diagnosis of gout have a recorded CVD risk assessment score |
≥90% |
5.2 Adult patients with a diagnosis of gout and a 10 yr risk of CVD ≥20% are prescribed lipid lowering therapy |
≥75% |
||
Diuretic therapy should be stopped if possible in patients with a diagnosis of gout [3,4] | 5.3 Adult patients with a diagnosis of gout currently taking diuretics | <25% |
CVD, Cardiovascular disease; eGFR, Estimated glomerular filtration rate; SUA, Serum uric acid.